BioWorld MedTech

July 30, 2013

Midwest firms raise $351 million; device funding up over pharma

Medical devices have outpaced pharmaceutical companies in terms of raising investment dollars from venture capitalist, according to the BioEnterprise (Cleveland) Midwest Venture Investment Report. Read More

FORMAT study to evaluate Formula 535 stent for PAD

Deals roundup: PPG to divest Transitions interest; will receive $1.7B

Washington roundup: NICE floats trial coverage of TAVR for high-risk patients

International report: InSightec's ExAblate wins Chinese market approval

Agreements/contracts: Positron enters into radioisotope agreement with iThemba LABS

Financings roundup: ReVision Optics raises $55M to support Raindrop inlay

People in the News

Med-Tech Notes

Product Briefs

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for April 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 14, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...